Latest Infrastructure News

Emyria Limited is scaling up its Perth Empax clinic with increased therapist approvals and treatment rooms, setting the stage for broader national clinical growth next year.

Alchemy Resources has reported further high-grade iron ore intercepts at its Valley Bore Project in Western Australia, confirming mineralisation over a 600m strike length with strong potential for expansion. The company’s joint venture option with Newcam Minerals adds strategic momentum to the project’s development prospects.

APA Group has announced a modest 1.9% increase in its interim distribution to 27.5 cents per security for the half year ending December 2025, maintaining steady income growth for investors.

APA Group has announced an estimated ordinary dividend of AUD 0.275 per fully paid unit for the six months ending December 2025, alongside a Dividend Reinvestment Plan offering a 1.5% discount. The final dividend will be confirmed in February 2026.

Beetaloo Energy has reached a Final Investment Decision for its Carpentaria Pilot Project, paving the way for gas sales from EP187 starting in 2026. This milestone follows key agreements and approvals, marking a significant step in Northern Territory’s energy development.

Brazilian Rare Earths Limited’s scoping study confirms the Amargosa Bauxite-Gallium Project as a large-scale, capital-efficient direct-ship bauxite operation with robust economic returns and strategic market positioning.

Native Mineral Resources reports steady gold production at Blackjack with 1,300 ounces yielded and $7.6 million revenue, while advancing regulatory and joint venture developments.

Jameson Resources has raised an extra A$450,000 through a discounted share placement, reinforcing investor confidence in its Crown Mountain coal project amid ongoing regulatory progress.

Fenix Resources unveils a robust three-year plan to ramp up iron ore production from 2.4Mt in FY25 to 6Mtpa by FY28, anchored by its Weld Range Project. The company also raises FY26 guidance and initiates feasibility studies for further expansion.

Neurizon Therapeutics has secured FDA clearance for its lead drug candidate NUZ-001 to enter the HEALEY ALS Platform Trial, marking a key regulatory milestone and setting the stage for patient enrollment in early 2026.

Marmota Limited’s maiden drilling program at the Greenewood gold discovery in South Australia reveals spectacular bonanza-grade gold assays over nearly 1km strike length, positioning the project as a standout in the Gawler Craton.

VRX Silica Limited has expanded its Arrowsmith North project’s offtake commitments by 550,000 tonnes annually and appointed Pareto Securities to manage debt financing, reinforcing its path to production.